Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Pyruvate metabolism pathway enzymes" refers collectively to a set of key metabolic enzymes that catalyze the conversion of pyruvate into various downstream products. These include: 1. Pyruvate dehydrogenase complex – Converts pyruvate into acetyl-CoA for entry into the citric acid cycle[1][2][4]. 2. Lactate dehydrogenase – Catalyzes reversible conversion between pyruvate and lactate during anaerobic glycolysis[2][3]. 3. Pyruvate carboxylase – Converts pyruvate to oxaloacetate for gluconeogenesis and anaplerosis[2][3]. 4. Alanine transaminase (ALT) – Interconverts alanine and pyruvate in amino acid metabolism[3]. These enzymes are tightly regulated by allosteric effectors, feedback inhibition, phosphorylation/dephosphorylation cycles, and hormonal signals such as insulin and glucagon[2]. They play central roles in cellular energy homeostasis by linking glycolysis with aerobic respiration (citric acid cycle), anaerobic fermentation (lactate), gluconeogenesis, amino acid cycling (alanine), and overall redox balance. There is no universal biomarker for all pyruvate metabolism pathway enzymes; however, individual enzyme activities or metabolites such as lactate, alanine, or acetyl-CoA may serve as biomarkers in specific clinical contexts. Because "pyruvate metabolism pathway enzyme" is not a single molecular entity but rather a functional category encompassing several distinct proteins with different structures and regulatory mechanisms, it is not considered a canonical therapeutic target itself—though individual members like *pyruvate dehydrogenase complex* or *lactate dehydrogenase* are well-established drug targets in oncology and metabolic disease research. Note: No single drug targets all "pyruvate metabolism pathway enzymes" as a group; drugs typically target specific enzymes within the pathway. Therefore: The entry "Pyruvate metabolism pathway enzymes" is too broad/vague for structured data about a single molecular target; it should be replaced with specific enzyme names such as "Pyruvate dehydrogenase complex," "Lactate dehydrogenase," etc.[1][2] If you need structured information on any one of these individual targets—for example *pyruvate dehydrogenase complex*, *lactate dehydrogenase*, etc.—please specify which one.
Inhibition or activation of specific enzyme activity (e.g., dichloroacetate inhibits pyruvate dehydrogenase kinase to activate the pyruvate dehydrogenase complex)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyruvate metabolism pathway enzyme.